CD274 and hepatocellular carcinoma: Because the increased infiltration and activation of Tregs and the increased expression of PD-L1 in HCC tissues have been associated with poor prognoses [23,24,40], our results suggest that inhibitors targeting Tregs and PD-L1 are promising therapeutics for treating HCC patients infected with HBV with pre-S gene deletions.